Interference with P-glycoprotein improves ivermectin activity against adult resistant nematodes in sheep

A Lifschitz1, C Entrocasso, L Alvarez

  • 1Departamento de Fisiopatología, UNCPBA, Campus Universitario, 7000 Tandil, Argentina. adrianl@vet.unicen.edu.ar

Insights

Co-administering ivermectin (IVM) with loperamide (LPM) significantly boosted IVM

Area of Science:

  • Veterinary Parasitology
  • Pharmacokinetics
  • Drug Interactions

Background:

  • Ivermectin (IVM) resistance in nematodes is a growing concern in ruminant health.
  • P-glycoprotein (P-gp) efflux pumps contribute to IVM resistance in parasites.
  • Modulating P-gp activity may enhance IVM efficacy against resistant helminths.

Purpose of the Study:

  • To investigate the effect of loperamide (LPM), a P-gp modulator, on IVM pharmacokinetics and anthelmintic efficacy in lambs infected with IVM-resistant nematodes.
  • To assess the impact of LPM-IVM co-administration on parasite egg counts and adult worm burdens.

Main Methods:

  • Eighteen lambs with naturally acquired IVM-resistant nematode infections were used.
  • Groups received IVM alone or IVM co-administered with LPM.
  • Faecal egg counts (FECRT), plasma IVM concentrations (HPLC), and adult worm burdens were assessed.

Main Results:

  • LPM co-administration increased IVM plasma availability and prolonged its elimination half-life.
  • Faecal egg count reduction increased from 78.6% (IVM alone) to 96% (IVM+LPM).
  • Efficacy against resistant Haemonchus contortus increased from 0% to 72.5% with LPM co-administration.

Conclusions:

  • Loperamide enhances ivermectin's systemic exposure and efficacy against resistant nematodes in lambs.
  • P-gp modulation by LPM is a promising strategy to overcome IVM resistance in veterinary parasitology.
  • This approach could improve the control of resistant gastrointestinal nematodes in ruminants.